Morepen Laboratories surged 8.90% to Rs 46.61 after the company launched Empamore, an affordable treatment for type 2 diabetes, heart failure, and chronic kidney disease in India.
91%), according to the poster. Lastly, researchers asked allergists to rank five second-generation antihistamines — cetirizine, desloratadine, fexofenadine, levocetirizine and loratadine — by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback